| pubmed-article:19365131 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0151744 | lld:lifeskim |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0205146 | lld:lifeskim |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:19365131 | lifeskim:mentions | umls-concept:C0035124 | lld:lifeskim |
| pubmed-article:19365131 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19365131 | pubmed:dateCreated | 2009-6-26 | lld:pubmed |
| pubmed-article:19365131 | pubmed:abstractText | Clinical differentiation between infarcted and viable myocardium in the ischemic area at risk is controversial. We investigated the potential of contrast-enhanced cardiac magnetic resonance imaging (ceCMRI) in determining the area at risk 24 h after ischemia. | lld:pubmed |
| pubmed-article:19365131 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19365131 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19365131 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19365131 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19365131 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19365131 | pubmed:issn | 1421-9921 | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:HoffmannNN | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:KENTA EAE | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:BeckerDD | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:PetersenS ESE | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:LauterbachMM | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:DüberCC | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:MunzelTT | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:HorstickGG | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:GorePP | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:BierbachBB | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:KreitnerK-FKF | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:Abegunewarden... | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:VosselerMM | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:CleppienDD | lld:pubmed |
| pubmed-article:19365131 | pubmed:author | pubmed-author:SchreiberL... | lld:pubmed |
| pubmed-article:19365131 | pubmed:copyrightInfo | Copyright (c) 2009 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:19365131 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19365131 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:19365131 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19365131 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19365131 | pubmed:pagination | 13-23 | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:meshHeading | pubmed-meshheading:19365131... | lld:pubmed |
| pubmed-article:19365131 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19365131 | pubmed:articleTitle | Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast-enhanced cardiac magnetic resonance imaging. | lld:pubmed |
| pubmed-article:19365131 | pubmed:affiliation | 2nd Medical Clinic, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, Mainz, Germany. | lld:pubmed |
| pubmed-article:19365131 | pubmed:publicationType | Journal Article | lld:pubmed |
